166
Participants
Start Date
October 31, 2001
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2010
CHOEP + G-CSF followed by BEAM
"CHOEP:~Cyclophosphamide: 750 mg/m2 i.v. day1 Hydroxydaunorubicin: 50 mg/m2 i.v. day1 Vincristine: 1.4 mg/m2 (max 2 mg) i.v. day 1 Etoposide: 100 mg/m2 i.v. day 1-3 Prednisone: 100 mg daily p.o. day 1-5~BEAM:~Carmustine: 300 mg/m2 i.v. day 1 Etoposide: 100 mg/m2 i.v. x2 daily day 2-5 Cytosine arabinoside: 200 mg/m2 i.v. x2 daily or 400 mg/m2 as continuous 24 hrs i.v. infusion, day 2-5 Melphalan: 140 mg/m2 i.v. day 6"
St.Olavs Hospital, Trondheim
Aarhus University Hospital, Aarhus
Kuopio University Hospital, Kuopio
Copenhagen Hospital, Copenhagen
Vejle Hospital, Vejle
OULO University Hospital, Oulu
Rogaland Hospital, Rogaland
Oslo University Hospital, Oslo
Ullevaal University Hospital, Oslo
Nordic Lymphoma Group
NETWORK
University of Aarhus
OTHER